1980023-97-9
C10H13Cl2FN4
279.14
98%
Non-small cell lung cancer
Pralsetinib
2-4 weeks
ISO 9001
CDMO
| Availability: | |
|---|---|
Product Description
This compound is an intermediate for Pralsetinib. In contrast to the compound CAS No. 2097133-17-8 that has one hydrochloride molecule, this compound is the dihydrochloride form.
content is empty!